Difference between revisions of "Category:Antibody medications"
Jump to navigation
Jump to search
(Created page with "A class of agents that are for the most part engineered monoclonal antibodies. Includes drug conjugates, which are typically denoted by a second name, e.g. [[Brentuximab vedot...") |
m |
||
| Line 1: | Line 1: | ||
| − | A class of agents that are for the most part engineered monoclonal antibodies. Includes drug conjugates, which are typically denoted by a second name, e.g. [[Brentuximab vedotin (Adcetris)|brentuximab ''vedotin'']]. | + | A class of agents that are for the most part engineered monoclonal antibodies. Includes drug conjugates, which are typically denoted by a second name, e.g. [[Brentuximab vedotin (Adcetris)|brentuximab ''vedotin'']]. Note that some monoclonal antibodies operate through immunotherapeutic mechanisms, whereas others are directly cytotoxic (and some are both). |
| + | |||
| + | [[Category:Chemotherapy]] | ||
| + | [[Category:Immunotherapy]] | ||
Revision as of 15:22, 26 November 2014
A class of agents that are for the most part engineered monoclonal antibodies. Includes drug conjugates, which are typically denoted by a second name, e.g. brentuximab vedotin. Note that some monoclonal antibodies operate through immunotherapeutic mechanisms, whereas others are directly cytotoxic (and some are both).
Subcategories
This category has the following 6 subcategories, out of 6 total.